Log In
Print this Print this

Mozobil, plerixafor (AMD3100)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSynthetic CXC chemokine receptor 4 (CXCR4) antagonist
Molecular Target CXC chemokine receptor 4 (CXCR4) (NPY3R)
Mechanism of ActionCXC chemokine receptor 4 (CXCR4) antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today